Seattle Urology Research Center
Quick facts
Marketed products
- Solifenacin PO · Urology
Solifenacin is a muscarinic M3 receptor antagonist that reduces bladder muscle contractions to treat overactive bladder.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Seattle Urology Research Center portfolio CI brief
- Seattle Urology Research Center pipeline updates RSS
Frequently asked questions about Seattle Urology Research Center
What are Seattle Urology Research Center's marketed drugs?
Top marketed products include Solifenacin PO.
Related
- Solifenacin PO · Urology
- Sector hub: All tracked pharma companies